Based on current knowledge, we hypothesize that IM dysbiosis is a key driver of intestinal Mrp2 downregulation in diet-induced obesity, impairing its barrier function via downstream factors, with inflammation and OS as the main candidates. Here, ABCC2 is linked to obesity disorder.